Use access key #2 to skip to page content.
$6.74 -0.07 (-1.03%)
10/6/2008 4:00 PM

Repros Therapeutics, Inc. (RPRX)

CAPS Rating:
*

A biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders.

View All Commentary (RPRX)

Recs

0

Avatar ProphetOfProfits (97.76) Submitted: 7/27/07 10:59 AM : Outperform Start Price: $13.20 RPRX Score: -20.04

Good clinical data re Proellex safety is a good enough reason for me to hop in again

Report this Post Replies: 0 | Reply

Featured Broker Partners